However, Stacie Dusetzina, a drug pricing expert at Vanderbilt University Medical Center, cautioned that the full impact remains unclear. “This is a critical step forward in our work to improve healthcare, especially for low-income Americans,” Trump said. (Related: Trump gives Big Pharma 60 days to cut drug prices or face government crackdown.) The Pfizer-Trump deal represents a significant shift in pharmaceutical pricing, but its real-world impact depends on execution. Yet as Dusetzina noted, “this is not a solution for lowering drug prices” for most Americans.